Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Replisome dysfunction upon inducible TIMELESS degradation synergizes with ATR inhibition to trigger replication catastrophe. | Nucleic Acids Res | 2023 | 37144518 | PubTator, text mining | PubMed |
| Nucleotide excision repair in Human cell lines lacking both XPC and CSB proteins. | Nucleic Acids Res | 2023 | 37144462 | PubTator, text mining | PubMed |
| Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients. | Nat Commun | 2023 | 37142601 | PubTator, text mining | PubMed |
| Effect of ERCC1 polymorphisms on the response to platinum-based chemotherapy: A systematic review and meta-analysis based on Asian population. | PLoS One | 2023 | 37141338 | PubTator, text mining | PubMed |
| MSH2-MSH3 promotes DNA end resection during homologous recombination and blocks polymerase theta-mediated end-joining through interaction with SMARCAD1 and EXO1. | Nucleic Acids Res | 2023 | 37140056 | PubTator, text mining | PubMed |
| A pathogenic variant in the uncharacterized RNF212B gene results in severe aneuploidy male infertility and repeated IVF failure. | HGG Adv | 2023 | 37124137 | PubTator, text mining | PubMed |
| Assessing the biogeography of marine giant viruses in four oceanic transects. | ISME Commun | 2023 | 37120676 | PubTator, text mining | PubMed |
| Accurate transcriptome-wide identification and quantification of alternative polyadenylation from RNA-seq data with APAIQ. | Genome Res | 2023 | 37117035 | PubTator, text mining | PubMed |
| Cisplatin in Ovarian Cancer Treatment-Known Limitations in Therapy Force New Solutions. | Int J Mol Sci | 2023 | 37108749 | PubTator, text mining | PubMed |
| The Current Status of DNA-Repair-Directed Precision Oncology Strategies in Epithelial Ovarian Cancers. | Int J Mol Sci | 2023 | 37108451 | PubTator, text mining | PubMed |
| Pathway choice in the alternative telomere lengthening in neoplasia is dictated by replication fork processing mediated by EXD2's nuclease activity. | Nat Commun | 2023 | 37105990 | PubTator, text mining | PubMed |
| Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature. | Thorac Cancer | 2023 | 37095004 | PubTator, text mining | PubMed |
| Fanconi anemia-associated chromosomal radial formation is dependent on POLθ-mediated alternative end joining. | Cell Rep | 2023 | 37086407 | PubTator, text mining | PubMed |
| Lesion recognition by XPC, TFIIH and XPA in DNA excision repair. | Nature | 2023 | 37076618 | PubTator, text mining | PubMed |
| Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification. | J Proteome Res | 2023 | 37071664 | PubTator, text mining | PubMed |
| Benzo[a]pyrene stress impacts adaptive strategies and ecological functions of earthworm intestinal viromes. | ISME J | 2023 | 37069233 | PubTator, text mining | PubMed |
| Cellular resistance mechanisms in cancer and the new approaches to overcome resistance mechanisms chemotherapy. | Saudi Med J | 2023 | 37062547 | PubTator, text mining | PubMed |
| Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases. | Transl Neurodegener | 2023 | 37055865 | PubTator, text mining | PubMed |
| Atorvastatin Can Modulate DNA Damage Repair in Endothelial Cells Exposed to Mitomycin C. | Int J Mol Sci | 2023 | 37047754 | PubTator, text mining | PubMed |
| The Molecular Mechanisms and Therapeutic Prospects of Alternative Lengthening of Telomeres (ALT). | Cancers (Basel) | 2023 | 37046606 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=15